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Mitochondria appear to play an important role in the regulation of cerebral vascular tone. Recent, lim-
ited evidence shows that mitochondria-derived factors pro-
mote relaxation of intact or endothelium-denuded cerebral 
arteries or isolated vascular smooth muscle (VSM) cells.1–4 
Mitochondrial depolarization in VSM with diazoxide, an 
activator of mitochondrial ATP-sensitive potassium (mito-
KATP) channels, promotes the generation of reactive oxygen 
species (ROS) from mitochondria, which sequentially causes 
the activation of ryanodine-sensitive Ca2+ channels on sarco-
plasmic reticulum, generation of calcium transients, otherwise 
known as calcium sparks, and the opening of adjacent large-
conductance calcium-activated potassium channels (BKCa) 
on the plasma membrane. The efflux of K+ thus leads to 
hyperpolarization, decreased global intracellular Ca2+ of VSM, 
and vasodilation.1,2 However, the contribution of endothelium 
to the integrated cerebral arterial response to mitochondrial 
depolarization as well as to other potential mechanisms has 
never been systematically investigated.
See accompanying editorial on page 673
Our laboratory has provided physical and pharmacologi-
cal evidence that selective mitochondrial depolarizing agents 
promote endothelium-dependent vasodilation/vasoconstric-
tion by inducing the release of factors such as nitric oxide 
and constrictor prostaglandins, which modulate VSM effects 
in cerebral arteries.3 However, the precise mechanisms by 
which endothelial mitochondrial depolarization promotes 
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Objective—Mitochondrial depolarization after ATP-sensitive potassium channel activation has been shown to induce 
cerebral vasodilation by the generation of calcium sparks in smooth muscle. It is unclear, however, whether mitochondrial 
depolarization in endothelial cells is capable of promoting vasodilation by releasing vasoactive factors. Therefore, 
we studied the effect of endothelial mitochondrial depolarization by mitochondrial ATP-sensitive potassium channel 
activators, BMS-191095 (BMS) and diazoxide, on endothelium-dependent vasodilation.
Approach and Results—Diameter studies in isolated rat cerebral arteries showed BMS- and diazoxide-induced vasodilations 
that were diminished by endothelial denudation. Mitochondrial depolarization-induced vasodilation was reduced by 
inhibition of mitochondrial ATP-sensitive potassium channels, phosphoinositide-3 kinase, or nitric oxide synthase. 
Scavenging of reactive oxygen species, however, diminished vasodilation induced by diazoxide, but not by BMS. 
Fluorescence studies in cultured rat brain microvascular endothelial cells showed that BMS elicited mitochondrial 
depolarization and enhanced nitric oxide production; diazoxide exhibited largely similar effects, but unlike BMS, increased 
mitochondrial reactive oxygen species production. Measurements of intracellular calcium ([Ca2+]i) in cultured rat brain 
microvascular endothelial cells and arteries showed that both diazoxide and BMS increased endothelial [Ca2+]i. Western 
blot analyses revealed increased phosphorylation of protein kinase B and endothelial nitric oxide synthase (eNOS) by BMS 
and diazoxide. Increased phosphorylation of eNOS by diazoxide was abolished by phosphoinositide-3 kinase inhibition. 
Electron spin resonance spectroscopy confirmed vascular nitric oxide generation in response to diazoxide and BMS.
Conclusions—Pharmacological depolarization of endothelial mitochondria promotes activation of eNOS by dual pathways 
involving increased [Ca2+]i as well as by phosphoinositide-3 kinase-protein kinase B–induced eNOS phosphorylation. 
Both mitochondrial reactive oxygen species–dependent and –independent mechanisms mediate activation of eNOS by 
endothelial mitochondrial depolarization.  (Arterioscler Thromb Vasc Biol. 2013;33:752-759.)
Key Words: BMS-191095 ◼ diazoxide ◼ intracellular calcium ◼ membrane potential ◼ mitochondrial  
ATP-sensitive potassium channels ◼ superoxide
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endothelium-dependent vasodilation cannot be elucidated 
from previous studies. The ability of endothelial mitochon-
drial depolarization to affect cerebrovascular tone is a novel 
and potentially important area of investigation, as many physi-
ological, pharmacological, pathological, and physical factors 
impacting endothelium has been shown in other regional cir-
culations,5–11 but not yet in the cerebral circulation.
Two relatively selective openers of mitoKATP channels, 
diazoxide and BMS-191095 (BMS), are available, and we 
have studied their properties extensively in isolated mitochon-
dria, cultured neurons, and astrocytes.12–16 Although both depo-
larize mitochondria, diazoxide, but not BMS, causes increased 
production of ROS from mitochondria presumably by inhib-
iting succinate dehydrogenase.17 We12,13,16 and others18–21 are 
unaware of any effects of BMS other than as an opener of 
mitoKATP channels. No previous studies have examined the 
effects of BMS on cerebral arterial tone, and the endothelium-
specific effects of diazoxide have not been specifically stud-
ied. In this study, we examined the effect of mitochondrial 
depolarization in endothelium on integrated cerebral vascular 
tone and explored the mechanisms involved. Our results have 
allowed us to document the key elements of signaling steps 
that link mitochondrial depolarization with the generation of 
nitric oxide (NO) by cerebral vascular endothelium, includ-
ing activation of endothelial nitric oxide synthase (eNOS) by 
dual pathways involving increased [Ca2+]i as well as by phosh-
poinositide 3-kinase (PI3K)-protein kinase B (Akt)–induced 
phosphorylation.
Results
Intraluminal Diameter Measurements
The resting diameters of the cerebral arteries were similar for 
each group of experiments (169±4, n=91, in endothelium-
intact and 163±4, n=19, in endothelium-denuded; P=NS), and 
they were preconstricted to a similar degree (52±1, n=34, in 
endothelium-intact and 51±2, n=14, in endothelium-denuded; 
P=NS). The BMS elicited a dose-dependent vasodilation 
in cerebral arteries with 16.3±1.4%, 49.7±4.7%, and 
62.6±4.4% relaxation in response to 10, 50, and 100 µmol/L, 
respectively (n=6–12). Similarly, diazoxide elicited a dose-
dependent vasodilation with 8.9±1.2%, 21.9±2.9%, and 
39.5±2.8% relaxation in response to 10, 50, and 100 µmol/L, 
respectively (n=10; Figure 1). Denudation of endothelium 
diminished vasodilation to BMS with 5.9±0.9%, 31.6±2.1%, 
and 38.1±3.8% relaxation in response to 10, 50, and 100 
µmol/L, respectively (n=10; P<0.05). Similarly, denudation 
of endothelium diminished vasodilation to diazoxide with 
4.8±1.3%, 11.7±3.5%, and 28.5±2.3% relaxation in response to 
10, 50, and 100 µmol/L, respectively (n=9; P<0.05; Figure 1). 
Thus, endothelium contributes to vasodilation in response to 
both BMS and diazoxide.
Scavenging of the ROS with MnTBAP did not affect 
vasodilation to BMS (51.1±4.3, n=5; P=NS) confirming 
that BMS-induced vasodilation was independent of ROS 
generation (Figure 2A). In contrast, MnTBAP diminished 
vasodilation to diazoxide (8.6±1.3, n=5; P<0.05) confirm-
ing that diazoxide-induced vasodilation was ROS-dependent 
(Figure 2B). Inhibition of mitoKATP channels alone with 
5-hydroxydeconoic acid (11.7±2%, n=14; P<0.05) and 
fluoxetine (19.5±4%, n=5; P<0.05), or both mitochondrial 
and plasma membrane KATP with glibenclamide (22.3±4%, 
n=6; P<0.05) decreased vasodilation to BMS in endothe-
lium-intact arteries (Figure 2A). Wortmannin pretreatment 
Figure 1. Responses to BMS-191095 (BMS) and diazoxide (10, 
50, and 100 µmol/L) in endothelium-intact and -denuded cerebral 
arteries from Sprague Dawley (SD) rats after development of 
myogenic tone are shown. Data are mean±SEM of 6 to 14 exper-
iments. * and † indicate significant difference in corresponding 
response in endothelium-intact arteries with respect to BMS and 
diazoxide, respectively (P<0.05).
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Figure 2. Vascular responses to 50 μmol/L BMS-
191095 (A) and diazoxide (B) in endothelium-intact 
rat cerebral arteries in the presence and absence 
of 100 μmol/L manganese(III) tetrakis(4-benzoic 
acid)porphyrin chloride (MnTBAP), 1 mmol/L 
5-hydroxydeconoic acid (5-HD), 5 μmol/L fluox-
etine, 10 μmol/L glibenclamide, 100 nmol/L 
wortmannin, and 100 μmol/L Nω-nitro L-arginine 
methyl ester (L-NAME) are shown as bar graphs. 
In addition, vascular responses to 50 μmol/L BMS-
191095 and diazoxide in endothelium-denuded 
rat cerebral arteries are also displayed in the bar 
graphs. Data are mean±SEM of 4 to 14 experi-
ments. * and † indicate significant difference in 
corresponding response in endothelium-intact 
arteries with respect to BMS-191095 and diazox-
ide respectively (P<0.05).
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reduced the vasodilation to 50 µmol/L BMS (25.6±2.4%, 
n=5; P<0.05) and 50 µmol/L diazoxide (10.6±1.4%, n=5; 
P<0.05), implicating PI3K in the vasodilation. Finally, inhi-
bition of NOS with L-NAME resulted in diminished vaso-
dilation to 50 µmol/L BMS (25.6±4%, n=8; P<0.05) and 50 
µmol/L diazoxide (10.4±1.2%, n=6; P<0.05), suggesting that 
the major part of the vasodilation to BMS and diazoxide was 
mediated by NO (Figure 2A and 2B).
Arteries took ≈20 to 30 minutes to attain a stable diameter 
both before and after the administration of pharmacologi-
cal agents. In general, addition of pharmacological block-
ers had minimal effects on the diameter of preconstricted 
arteries. When compared with vehicle-treated arteries 
(0.5±0.4%, n=27), pretreatment with L-NAME (8.9±1.2%, 
n=14; P<0.05) caused slight constriction of arteries, whereas 
pretreatment with wortmannin (8.2±5%, n=5; P<0.05) 
caused only slight vasodilation. However, pretreatment 
with MnTBAP (0.45±0.7%, n=10), 5-hydroxydeconoic acid 
(0.6±1%, n=14), fluoxetine (–0.7±4%, n=5), and gliben-
clamide (–0.1±1%, n=6) had no significant effect on vascular 
diameter.
Mitochondrial Membrane Potential, [Ca2+]i,  
NO, and Mitochondrial ROS Measurements
The BMS and diazoxide depolarized the mitochondria 
of CMVECs indicated by reduction of rhodamine 123 
fluorescence compared with vehicle-treated cells (Figure 3A 
and 3E). Background subtracted rhodamine 123 fluorescence 
Figure 3. Fluorescence images of cultured primary rat brain microvascular endothelial cells (CMVECs) loaded with various fluores-
cent probes treated with vehicle (DMSO) or 50 µmol/L BMS-191095 (BMS) or 100 µmol/L diazoxide are shown. Fluorescence images 
of CMVECs loaded with rhodamine 123, a mitochondrial membrane potential marker, are shown in A. Mitochondrial depolarization 
is marked by the decrease in fluorescence. Fluorescence images of MitoSOX, a mitochondrial ROS-sensitive dye, are shown in B. 
C, Images of CMVECs loaded with 4-amino-5-methylamino-2′,7′-difluorofluorescein diacetate (DAF-FM), a nitric oxide (NO)-sensitive 
dye, and treated with or without Nω-nitro L-arginine methyl ester (L-NAME). Electron spin resonance (ESR) spectra of rat aortas incubated 
for 90 minutes at 37°C with 0.4 mmol/L colloid iron diethyldithiocarbamate ,Fe2+(DETC)2, are shown in D. The vertical axis represents 
signal intensity in arbitrary units, and the horizontal axis represents the magnetic field (G). A characteristic NO–Fe(DETC)2 signal with 3 
peaks (indicated by arrows) was detected in rat aortas incubated with Fe(DETC)2 and various drugs. The representative ESR spectra of 
the basal (vehicle-treated), 100 µmol/L diazoxide, 50 µmol/L BMS, and 10 µmol/L spermine NONOate (10 µmol/L, N-[2-Aminoethyl]-N-
[2-hydroxy-2-nitrosohydrazino]-1,2-ethylenediamine)-treated aortas are shown along with the cumulative data expressed as percentage 
change from basal level as a bar graph (G). The cumulative data of fluorescence intensity from the images were determined and plotted 
as a bar graph for rhodamine 123, MitoSOX, and DAF-FM (E and F). In E, *significant difference in response vs vehicle for corresponding 
fluorescent probes (P<0.05). In F, * and † indicate significant difference in response vs vehicle and untreated BMS or diazoxide, respec-
tively (P<0.05). In G, * indicates significant difference in response vs basal level of normalized NO–Fe(DETC)2 signal (P<0.05).
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(arbitrary units) was reduced to 4.6±0.3 by BMS (n=6) 
and 6.5±0.4 by diazoxide (n=8) treatment versus 14.4±1, 
in vehicle-treated (n=6) cells. Measurements of MitoSOX 
fluorescence (arbitrary units) showed that BMS-treated 
CMVECs did not display increased fluorescence (10±1.3, 
n=5; P=NS) compared with the vehicle (13.3±0.6, n=8), 
indicating ROS production from mitochondria was 
unchanged (Figure 3B and 3E). In contrast, diazoxide 
treatment enhanced the fluorescence (18.2±0.9, n=7; P<0.05) 
compared with vehicle-treated cells, indicating generation 
of ROS (Figure 3B and 3E). In addition, normalized 
measurements of DAF-FM in CMVECs showed increased 
fluorescence intensity in response to BMS (164±10%, n=7; 
P<0.05) and diazoxide (182±23%, n=6; P<0.05) compared 
with the vehicle (100±11% and 100.1±12%, respectively; 
n=6 each), indicating generation of NO. Inhibition of 
NOS with L-NAME pretreatment of CMVECs abolished 
enhanced DAF fluorescence in response to BMS (47.3±4%, 
n=7; P<0.05) and diazoxide (28.2±12%, n=6; P<0.05) 
compared with response in untreated CMVECs. L-NAME 
pretreatment reduced the DAF-FM fluorescence in vehicle-
administered cells (50.3±4% and 33.3±11%, controls of 
BMS and diazoxide, respectively; n=6 each), however, this 
was a result of reduction in basal NO production that was 
sensitive to L-NAME. Thus, the increase in DAF fluorescence 
in response to BMS and diazoxide correlated with NOS-
derived NO production (Figure 3C and 3F). Measurements 
of fluo-4 acetoxymethyl ester (fluo-4 am)–loaded endothelial 
cells in freshly isolated cerebral arteries (Figure 4A and 
4C) showed increase in fluorescence in response to BMS 
(172±20%, n=7; P<0.05) and diazoxide (185±23%, n=5; 
P<0.05) compared with vehicle (100±15%, n=6). Similarly, 
fluo-4 AM–loaded CMVECs (Figure 4B and 4C) showed 
increase in fluorescence in response to BMS (23.6±3%, n=6; 
P<0.05) and diazoxide (25.7±3%, n=6; P<0.05) compared 
with vehicle (14.5±2%, n=6). In addition, treatment of 
CMVECs with 100 µmol/L BMS increased fluo-4 AM 
fluorescence (196±14%, n=4; P<0.05), but did not affect 
MitoSOX (100±7%, n=4; P=NS) fluorescence compared 
with vehicle-treated cells (145±8%, n=4 and 102±5%, n=4; 
respectively; Figure II in the online-only Data Supplement). 
Thus, endothelial cells exhibited an increase in fluo-4 AM 
fluorescence in response to BMS and diazoxide, indicating 
elevation of cytosolic [Ca2+]i in the cells.
NO Measurements by ESR
A characteristic NO–Fe(DETC)2 signal with 3 peaks (g value 
≈2.035) was detected in rat aortas incubated with Fe(DETC)2 
and various drugs. The magnitude of this signal was greatly 
increased by stimulation with the BMS (194±21%, n=6; 
P<0.05) or diazoxide (232±19%, n=6; P<0.05) compared 
with vehicle-treated aortas (100±0%, n=6; Figure 3D and 
3G). Furthermore, the ESR signals from BMS- or diazoxide-
stimulated aortas were abolished after addition of the NOS 
inhibitor, L-NAME.
Akt and eNOS Phosphorylation
Treatment of CMVECs with BMS (2.08±0.21, n=8; 
P<0.05) and diazoxide (1.83±0.17, n=8; P<0.05) led 
to increased phosphorylated-Akt/total-Akt ratio of 
immunoband intensity (arbitrary units), compared with 
vehicle treatment (1.12±0.13, n=8; Figure 5A and 5C). 
Similarly, treatment of arteries with BMS (1.31±0.03, 
n=5; P<0.05) and diazoxide (1.24±0.05, n=5; P<0.05) 
promoted increased phosphorylated-Akt/total-Akt ratio 
of immunoband intensity compared with vehicle-treated 
arteries (0.84±0.03, n=5; Figure 5A and 5C). Treatment 
of CMVECs with BMS (1.29±0.059, n=8; P<0.05) and 
diazoxide (1.29±0.06, n=8; P<0.05) led to increased 
phosphorylated-eNOS/total-eNOS ratio of immunoband 
intensity compared with vehicle-treated arteries (1.0±0.028, 
n=8; Figure 5A and 5D). Similarly, treatment of arteries with 
BMS (0.82±0.03, n=5; P<0.05) and diazoxide (1.01±0.06, 
n=5; P<0.05) induced increased phosphorylated-eNOS/
total-eNOS ratio of immunoband intensity compared with 
vehicle-treated arteries (0.72±0.03, n=5; Figure 5A and 
5D). In addition, the phosphorylated-eNOS/total-eNOS 
Figure 4. Fluorescence images of cerebral artery endothelial 
cells (A) and cultured primary rat brain microvascular endothelial 
cells (CMVECs; B) loaded with fluo-4 AM, a calcium-sensitive 
fluoroprobe, and treated with vehicle (DMSO) or 50 µmol/L BMS-
191095 (BMS). The cumulative data of fluorescence intensity 
from the images were determined and plotted as a bar graph 
in C. * and † indicate significant difference in response to BMS 
or diazoxide vs vehicle, in arterial endothelial cells or CMVECs, 
respectively (P<0.05).
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ratio of immunoband intensities showed an increase in 
response to diazoxide (1.15±0.05, n=6; P<0.05) compared 
with vehicle-treated CMVECs (0.98±0.04, n=6; P=NS), 
and wortmannin pretreatment abolished the diazoxide 
response (0.81±0.08, n=6; P<0.05; Figure 5B and 5E). 
Similarly, in cerebral arteries, the phosphorylated-eNOS/
total-eNOS ratio of immunoband intensities showed an 
increase in response to diazoxide (1.06±0.08, n=3; P<0.05) 
compared with vehicle-treated arteries (0.74±0.06, n=3; 
P=NS), and wortmannin pretreatment abolished diazoxide 
response (0.7±0.06, n=3; P<0.05; Figure 5B and 5E). Thus, 
pretreatment of CMVECs and arteries with wortmannin 
eliminated the increase in eNOS phosphorylation in 
response to diazoxide.
Discussion
There are 4 major, new findings of the study. First, mitochon-
drial depolarization in the presence as well as in the absence 
of ROS generation is a potent initiator of dilator responses 
of cerebral arteries. Second, mitochondrial depolarization-
induced relaxation involves contributions from endothelium as 
well as VSM. Third, the endothelium-dependent vasodilation 
induced by mitochondrial depolarization is mediated by NO 
resulting from activation of eNOS via increased endothelial 
[Ca2+]i and activation of PI3K leading to Akt phosphorylation. 
Fourth, both mitochondrial ROS-dependent and -indepen-
dent mechanisms are capable of promoting vasodilation by 
mitochondrial depolarization. Our observations indicate that 
mitochondrial factors specific to depolarization can have 
major influences on the regulation of cerebral vascular tone.
Our finding that activation of mitoKATP channels elicited 
vasodilation is consistent with previous studies from our 
laboratory3 and others,2 and in addition, demonstrates the 
importance of the endothelium. Scavenging of ROS reduced 
the vasodilation response to diazoxide alone, whereas BMS-
induced vasodilation was unaffected. Thus, the ability of 
mitochondrial depolarization by BMS to promote vasodila-
tion independent of ROS generation is a novel observation. 
Measurements of mitochondrial ROS in endothelial cells 
provided additional evidence that, unlike diazoxide, BMS 
does not enhance the generation of mitochondrial ROS. 
Furthermore, reduced vasodilation in response to BMS and 
diazoxide after endothelial denudation confirmed the impor-
tant contribution of endothelium to mitochondria-mediated 
vasodilation. Notably, the greater endothelial contribution to 
vasodilation in response to BMS versus diazoxide suggests 
that the ROS production by diazoxide may interfere with 
NO-dependent mechanisms.
Mitochondria-mediated vasodilation was also sensitive to 
inhibition of mitoKATP channels confirming their role in mito-
chondrial depolarization. Studies in our laboratory and others 
have demonstrated the role of mitoKATP channels in mediat-
ing the effects of diazoxide2,14,22 and BMS3,12,13,16,18,19,21,23,24 
in isolated mitochondria, neurons, vasculature, and cardio-
myocytes. Also, our laboratory has characterized the distinct 
ROS-independent mechanism of actions of BMS compared 
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Figure 5. Western blots of total and phosphorylated forms of Akt and endothelial nitric oxide synthase (eNOS) in homogenates of cul-
tured primary rat brain microvascular endothelial cells (CMVECs) and cerebral arteries treated with vehicle (control) or BMS-191095 (BMS) 
or diazoxide are shown (A). In B, Western blots of total and phosphorylated forms of eNOS in homogenates of CMVECs and cerebral 
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with diazoxide in isolated mitochondria and cultured corti-
cal neurons.12,16 The present study confirms our previous 
findings of ROS-independent actions of BMS in promoting 
mitochondria-mediated vasodilation.
Inhibition of NOS diminished vasodilation to BMS and 
diazoxide in endothelium-intact arteries indicating that part of 
the mitochondria-mediated vasodilation was NO-dependent 
vasodilation. This finding is consistent with our previous 
observations, which showed that diazoxide-induced 
vasodilation involved endothelium and NOS.3 Moreover, 
fluorescence measurements of NO in CMVECs confirmed 
the ability of BMS and diazoxide to enhance NO generation 
sensitive to NOS inhibition. Furthermore, measurements of 
NO by ESR provided additional evidence supporting the 
ability of BMS and diazoxide to promote NO generation 
in vascular tissues. Two potential mechanisms underlie the 
activation of eNOS in response to BMS and diazoxide: First, 
fluorescence measurements of Ca2+ showed elevation of 
intracellular Ca2+ in response to mitochondrial depolarization 
in CMVECs and also in endothelial cells of intact cerebral 
arteries, thus implicating [Ca2+]i in the production and release 
of endothelial-relaxing factors. Second, administration of 
wortmannin resulted in diminished vasodilation in response 
to BMS and diazoxide, implicating the PI3K pathway in 
vasodilation. Mitochondrial depolarization initiates key 
elements of cellular signaling, such as activation of Akt or 
increases in [Ca2+]i, events which are associated with direct 
effects on VSM and production of endothelium-dependent 
relaxing factors, such as NO and prostacyclin.3 For example, 
we have recently shown that insulin dilates cerebral arteries 
after activation of the PI3K and Akt system.25 Our findings 
showing that wortmannin reduced vasodilation to BMS and 
diazoxide are consistent with this mechanism, and similar 
findings have been reported in heart.21 In addition, BMS 
and diazoxide treatment of CMVECs and arteries promoted 
phosphorylation of Akt consistent with involvement of 
PI3K–Akt pathway in vasodilation.26 Our previous studies 
reported for the first time that mitochondrial depolarization 
leads to the activation of PI3K–Akt signaling pathway 
in cultured neurons,12 as opposed to PI3K–Akt pathway 
activation leading to alteration of mitochondrial membrane 
potential.27 Mitochondrial depolarization has been shown 
to increase localized calcium transients in the form of Ca2+ 
sparks in VSM2 without significant change in global [Ca2+]i, 
however, the exact mechanisms by which mitochondrial 
depolarization leads to an increase in [Ca2+]i, and activation 
of PI3K in endothelial cells needs further investigation. We 
believe that the mechanisms underlying the release of NO 
are likely to promote the release of non-NO factors, such 
as hydrogen peroxide, prostacyclin, and so on, contributing 
to mitochondria-mediated vasodilation. Furthermore, 
treatment of cerebral arteries and CMVECs with BMS and 
diazoxide resulted in increased phosphorylation of eNOS, 
further confirming the activation of eNOS by mitochondrial 
depolarization. Finally, wortmannin abolished the diazoxide-
induced increase in phosphorylation of eNOS in both 
CMVECs and arteries confirming the role of the PI3K 
pathway in mitochondria-mediated vasodilation.
Although this is a relatively new field of study, it appears 
that diverse physiological, pathological, and pharmacological 
factors can depolarize mitochondria in vascular cells. 
Depolarization of mitochondria in other nonvascular cells 
within the neurovascular unit, such as astroglia and neurons, 
might also lead to the production and release of substances, 
which could affect cerebral vascular tone. Thus, increased 
shear stress in coronary arteries, possibly through filamentous 
connections with the glycocalyx, can distort and activate 
mitochondrial-driven events resulting in production of dilator 
agents, such as hydrogen peroxide in mitochondria.28 Similarly, 
decreased oxygen levels can affect mitochondrial membrane 
potential in blood vessels.2,10 Furthermore, we have shown 
that drugs such as rosuvastatin also depolarize mitochondria 
in neurons.29 Thus, our findings have demonstrated for the first 
time the ability of mitochondrial depolarization to promote 
the release of endothelial-relaxing factors via increased [Ca2+]i 
and the PI3K–Akt–eNOS pathway.
Limitations
Our studies used pharmacological approaches to promote 
mitochondrial depolarization, and agents such as diazoxide 
have been shown to exhibit some nontarget and nonspecific 
mitochondrial effects. Many physiological/pathological 
stimuli (hypoxia)30,31 that promote mitochondrial depo-
larization are plagued by similar, but significantly greater 
Figure 6. A schematic of the proposed mechanisms underly-
ing the vasodilation induced by the mitochondrial depolariza-
tion in the endothelium. Depolarization of mitochondria leads to 
elevation of endothelial [Ca2+]i by both reactive oxygen species 
(ROS)-dependent and -independent mechanisms. Elevation 
of global endothelial [Ca2+]i promotes activation of endothelial 
nitric oxide synthase (eNOS), which, in turn, leads to generation 
of nitric oxide (NO). Mitochondrial depolarization in endothelial 
cells also promotes activation of phosphoinositide-3 kinase 
(PI3K), phosphorylation of Akt, and subsequently phosphoryla-
tion of eNOS resulting in [Ca2+]i-independent activation of eNOS 
leading to NO generation. Finally, mitochondrial depolarization-
induced endothelium-dependent vasodilation is primarily medi-
ated by NO, and this effect enhances vascular smooth muscle 
(VSM)-specific relaxation. Mitochondrial depolarization in VSM 
cells sequentially causes the activation of ryanodine-sensitive 
Ca2+ channels on sarcoplasmic reticulum, generation of calcium 
transients, calcium sparks, and the opening of adjacent large-
conductance calcium-activated potassium channels (BKCa) on 
the plasma membrane. The efflux of K+ thus leads to hyperpo-
larization, decreased global intracellular Ca2+ of smooth muscle, 
and vasodilation.
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nonspecific effects. Importantly, diazoxide is a widely used 
well-characterized mitochondrial agent. We and others 
have studied diazoxide and BMS in variety of cell types. 
Despite recent evidence,32 there is a lack of consensus on 
the molecular identity of the mitoKATP channel, specificity 
of its blockers, and their role in mitochondrial depolariza-
tion. Our purpose of using pharmacological agents was to 
achieve mitochondrial depolarization with minimal nontar-
get effects. The primary mechanisms of elevation of endo-
thelial global [Ca2+]i, phosphorylation of Akt, and eNOS in 
response to diazoxide and BMS were qualitatively similar, 
implicating mitochondrial depolarization as the common 
activator of these pathways.
In summary, our study has uncovered a novel mitochon-
dria-mediated mechanism of vasodilation in cerebral arter-
ies, which involves the release of endothelium-derived 
relaxing factors in response to mitochondrial depolarization. 
Activation of ROS-dependent and ROS-independent signaling 
pathways after mitochondrial depolarization leads to complex 
cellular events involving release of endothelial factors, which 
lead to a vascular response to match cerebral blood flow with 
metabolism.
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Mitochondria play an important role in the regulation of vascular tone. Recent, limited evidence shows that mitochondrial depolarization 
promotes relaxation of intact or endothelium-denuded arteries or isolated vascular smooth muscle cells. Mitochondrial depolarization occurs 
in physiological (metabolic demand) and pathological (hypoxia-ischemia) conditions. However, the exact mechanisms by which mitochondrial 
depolarization promotes the release of endothelial vasoactive factors have not been adequately studied. In the present study, we induced en-
dothelial mitochondrial depolarization by 2 mechanistically different selective activators of mitochondrial ATP sensitive potassium channels. 
We demonstrated that mitochondrial depolarization results in activation of endothelial NO synthase by dual pathways, involving increased 
intracellular calcium as well as by phosphoinositide-3 kinase-protein kinase B-induced endothelial NO synthase phosphorylation. Both mito-
chondrial reactive oxygen species-dependent and –independent mechanisms mediate activation of endothelial NO synthase by endothelial 
mitochondrial depolarization. Thus, present study provides the first evidence of the mechanism by which mitochondria may match metabolic 
demand with blood flow.
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MATERIALS AND METHODS 
Fluorescence Confocal Microscopy.  
1. Mitochondrial membrane potential was determined by using rhodamine 123, (ex: 488 nm, 
em: >505 nm long pass filter). 2. MitoSOX (ex: 405 nm, em: >560 nm long pass filter) was 
used to measure mitochondrial ROS, specifically superoxide, based on the method reported by 
Robinson et al 1. Several previous studies measured the MitoSOX fluorescence with ex: 488 nm, 
em: >560 nm. However, recent studies by Robinson et al 1 provided evidence that MitoSOX 
fluorescence, when the fluoroprobe is excited at a wave length of ex: 405 nm and emission is 
captured at a wavelgth of  em: >560 nm, is specific for measurement of superoxide. 3. Fluo-4 
AM (ex: 488 nm, em: 505 nm long pass filter) was used to study [Ca2+]i. 4. 4-amino-5-
methylamino- 2’,7’-difluorofluorescein diacetate (DAF-FM, ex: 488 nm, em: >505 nm long 
pass filter) was used to measure NO. The specificity of NO measurements was established by 
inhibition of NO generation by NOS with L-NAME. 
Stock solutions of fluoroprobes were prepared in DMSO. The CMVECs were loaded in 
the dark with a 1:1 mixture of mol/L fluo-4 AM or mol/L DAF-FM and 20% (w/v) pluronic 
F-127 diluted in PBS containing glucose (1g/L) for 30 min at room temperature. For [Ca2+]i 
measurements in arterial endothelial cells, freshly isolated rat posterior cerebral arteries were cut 
longitudinally, and pinned to a Sylgard block with the endothelium facing up as previously 
described. 2 Subsequently, fluo-4 AM was loaded, as described above, with the arterial segment 
pinned to the sylgard block, mounted in a vessel chamber with the endothelium facing the cover 
slip, and the objective on the inverted microscope. Cells were washed and incubated for a further 
30 min to allow for complete de-esterification of intracellular AM esters and diacetates. 
Rhodamine 123 (5 g/ml) or MitoSOX (mol/L) solutions were prepared in phenol-free 
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DMEM and CMVECs were loaded with fluoroprobes for 15 min at 37oC. Confocal microscopy 
was performed using a laser scanning confocal system (LSM 510 and 7 Live; Zeiss, Jena, 
Germany) attached to an inverted microscope with a Zeiss C-Apochromat 63X /NA 1.2 water 
immersion objective. MitoSOX fluorescence was determined by Leica SP2 AOB laser confocal 
microscope. Fluorescence images were acquired before and after application of vehicle (dimethyl 
sulfoxide, DMSO) or BMS (50 mol/L or 100 mol/L) or diazoxide (100 mol/L ) for 
rhodamine 123, fluo-4 AM, and MitoSOX whereas DAF-FM images were acquired with or 
without a 30 min L-NAME pretreatment of cells. Imaging conditions such as gain levels and 
laser power were held constant. Offline analysis of images to determine the average pixel 
intensity of endothelial cells in each field (n=20-30) was performed using ImageJ software 
(National Institute of Health, Bethesda, MD) and the results were expressed in relative 
fluorescence units (RFUs) expressed as % change from the baseline images prior to 
administration of vehicle or BMS or diazoxide. For each coverslip with cells, 10-15 randomly 
selected fields containing 15-20 cells were imaged following vehicle or BMS or diazoxide 
treatment. Average fluorescence intensity of all the cells in the image was determined first 
followed by determination of the average of all images acquired from each cover slip. The ‘n’ 
value represents average fluorescence intensity of all the cells from ‘n’ number of cover slips 
that were included with each treatment.   
NO Measurements 
The NO measurements were performed using electron spin resonance (ESR) 
spectroscopy using the previously published methods 3, 4 
Colloid Fe(DETC)2 spin trapping. DETC (7.2 mg/10ml) and FeSO4 7H2O 
(4.5mg/10ml) were separately dissolved under argon gas bubbling in two 10ml volumes of ice-
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cold modified Krebs–Hepes buffer (K-H) containing (in mmol/L) 99.01 NaCl, 4.69 KCl, 1.87 
CaCl2, 1.20 MgSO4, 25 NaHCO3, 1.03 K2HPO4, 20 sodium-HEPES, and 11.1 d-glucose, pH 
7.35. These were rapidly mixed to obtain a pale yellow-brown opalescent colloid Fe(DETC)2 
solution (0.4mmol/L) which was used immediately. Aortas were placed separately in 12-well 
plates, each filled with 1 ml K-H buffer, in the presence and absence vehicle (DMSO), BMS (50 
mol/L), diazoxide (100 mol/L), or spermine NONOate [10 mol/L, N-(2-Aminoethyl)-N-(2-
hydroxy-2-nitrosohydrazino)-1,2-ethylenediamine] to stimulate NOS. Colloid Fe(DETC)2 was 
then added to each well (0.4 mmol/L)) and incubated at 37 °C for 90 min. Separate experiments 
were completed to examine the effects of NOS inhibition by addition of NG-nitro-L-arginine 
methyl ester (L-NAME) to the incubation medium (final concentration 1mM). Incubations were 
also performed with colloid Fe(DETC)2 alone (without aortas) to correct for any background 
signals.  
ESR spectroscopy. After incubation, the aortic segments were removed and frozen in 
liquid nitrogen, and placed in the middle of a column of K-H buffer as follow: The needle-end 
was cut from a 1 ml syringe barrel, the plunger retracted 1.5 cm from the cut end, and aortic 
segments were placed into the syringe barrel, which was then filled with K-H buffer and frozen 
in liquid nitrogen. After freezing, the syringe was removed from the liquid nitrogen and warmed 
for 5 s; the plunger was then removed, and the remaining barrel was filled with K-H buffer and 
frozen in liquid nitrogen. The syringe was then re-warmed for 5 s, and the syringe plunger was 
used to push the frozen column out of the syringe barrel directly into a finger dewar (Noxygen 
Science Transfer & Diagnostics GmbH, Elzach, Germany) containing liquid nitrogen. The ESR 
spectra were obtained using a benchtop X-band EMX series ESR spectrometer (Bruker Biospin 
GmbH, Karlsruhe, Germany) using a high sensitivity SHQ microwave cavity in a finger dewar 
 at SZTE ALTALANOS ORVOSTUDOMANYI on March 21, 2013http://atvb.ahajournals.org/Downloaded from 
 5
filled with liquid nitrogen. The ESR spectrometer settings were as follows: microwave power 40 
mW, modulation amplitude 8 G center-field 2.03 g, sweep width 80 G, conversion time 80 msec, 
time constant 20 msec, sweep time 10.24 s, with 60 scans. Signals were quantified by measuring 
the total amplitude after correction of baseline. The amount of NO was determined by measuring 
the total amplitude of the ESR signal for each treatment and comparing it with the ESR signal 
amplitude of the signal following NO-donor spermine NONOate. Finally, diazoxide and BMS 
induced NO production in aortas are expressed as % change from basal levels (vehicle treated).  
A characteristic NO-Fe(DETC)2 signal with three peaks (g value approximately 2.035) 
was detected in rat aortas incubated with Fe(DETC)2 and various drugs. The amount of NO was 
determined by measuring the total amplitude of the ESR signal for each treatment and comparing 
with the ESR signal amplitude of the signal following NO-donor spermine NONOate. Finally, 
diazoxide and BMS induced NO production in aortas are expressed as % change from basal 
levels (vehicle treated) (Figure II). Furthermore, the ESR signals from BMS or diazoxide-
stimulated aortas were abolished after addition of the NOS inhibitor, L-NAME. 
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Figure I. Fluorescence images of CMVECs loaded with rhodamine 123, a mitochondrial 
membraine potential sensitive fluoroprobe and treated with vehicle (DMSO) or 50 mol/L BMS  
followed by depolarization with carbonyl cyanide 3-chlorophenylhydrazone (CCCP, a 
protonophore and uncoupler of oxidative phosphorylation in mitochondria). Treatment with 5 
mol/L CCCP abolished the rhodamine 123 fluorescence confirming the localization of the 
fluoroprobe to mitochondria and also specificity of changes in the rhodamine 123 fluorescence to 
changes in mitochondrial membrane potential in response to BMS and diazoxide. 
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Figure II. Fluorescence images of CMVECs loaded with various fluorescent probes and treated 
with vehicle (DMSO) or 50 mol/L and 100 mol/L BMS. Fluorescence images of CMVECs 
loaded with fluo-4 AM, fluoroprobe for calcium, are shown in panel A. Fluorescence images of 
MitoSOX, a mitochondrial ROS sensitive dye, are shown in panel B. The cumulative data of 
fluorescence intensity from the images were determined and plotted as a bar graph for Fluo-4 
AM and MitoSOX in panel C. (*) indicates significant difference in response versus vehicle for 
corresponding fluorescent probes (p<0.05). BMS promoted dose-dependent increase in fluo-4 
AM fluorescence compared with vehicle treated cells indicating elevation of intracellular Ca2+. 
However, BMS treatment even at 100 mol/L concentration fail to increase MitoSOX 
fluorescence in endothelial cells compared with vehicle treated cells. 
 Thus, it appears that even though diazoxide and 100 mol/L BMS elevate intracellular 
Ca2+ to a similar degree, diazoxide promoted mitochondrial ROS elevation in endothelial cells 
whereas BMS did not. Mitochondrial ROS generation may be triggered by both mitochondrial 
Ca2+ -dependent and -independent pathways. This elevation of mitochondrial Ca2+ in response to 
increase in intracellular Ca2+ by BMS may not be sufficient to induce detectable mitochondrial 
ROS generation in endothelial cells. Alternatively, BMS may have a different impact on 
mitochondrial Ca2+ uptake compared with diazoxide, which may explain the differences in the 
mitochondrial ROS generation in BMS and diazoxide treated cells. 
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MATERIALS AND METHODS 
The animal protocol was approved by the Institutional Animal Care and Use Committees 
of Wake Forest University Health Sciences and Tulane University School of Medicine. The 
investigation complies with the Guide for the Care and Use of Laboratory Animals published by 
the US National Institutes of Health. 1  Young, male Sprague Dawley rats (SD, n=32) were 
obtained at ten weeks of age for vascular experiments and two week old SD rats (n=50) were 
obtained for cell culture studies. Rats were housed in the animal care facility and received 
standard rat chow and tap water ad libitum. A detailed description of methods has been provided 
in the data supplement placed on the journal website. 
Vascular Reactivity. Rats were sacrificed under deep isoflurane inhalation anesthesia, 
decapitated and rat brains were isolated. Subsequently, the posterior cerebral arteries were 
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isolated and vasoreactivity was determined by measuring intraluminal diameter (Living Systems 
Instrumentation, Burlington, VT) as described previously.2, 3  Briefly, arteries were transferred to 
a vessel bath filled with oxygenated, warm, physiological salt solution (PSS), cannulated with 
glass pipettes and secured with nylon thread. Arteries were slowly pressurized with PSS until 
they developed a stable myogenic tone and cumulative concentration responses to drugs were 
determined. Endothelium was removed by injecting a bolus of 1 ml of air through the arteries 
and endothelial denudation was verified by lack of a response to bradykinin. 
 Vascular responses to BMS (10, 50, and 100 mol/L) or diazoxide (10, 50, and 100 
mol/L) were determined in both endothelium intact and denuded arteries. In addition, responses 
to 50 mol/L of BMS or diazoxide were evaluated in endothelium-intact arteries pretreated with 
manganese(III) tetrakis(4-benzoic acid)porphyrin chloride (MnTBAP, a SOD mimetic, 100 
mol/L), 5-hydroxydeconoic acid (5-HD, 1 mmol/L, a relatively selective inhibitor of mitoKATP 
channels), fluoxetine (an inhibitor of mitoKATP channels 4, 5 mol/L), glibenclamide (10 mol/L, 
a non-isoform specific KATP channel blocker), wortmannin (a PI3K inhibitor, 100 nmol/L), or 
N-nitro L-arginine methyl ester (L-NAME, a non-isoform selective NOS inhibitor, 100 
mol/L). 
Endothelial cell cultures. To evaluate the ability of mitochondrial depolarization to 
regulate endothelial factors, we determined mitochondrial membrane potential, mitochondrial 
ROS, NO, and intracellular [Ca2+]i levels in cultured primary rat brain microvascular endothelial 
cells (CMVECs). As described previously,5, 6 cortical microvessels were isolated and CMVECs 
were prepared from the brain cortices of two weeks old rats. Briefly, rats were decapitated under 
deep anesthesia and the brain cortices were freed from meninges, homogenized, and digested 
with DNase and collagenase. The homogenate was then centrifuged at 500 g for eight min at 4 
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oC. Subsequently, the supernatant was collected and redistributed in 20% bovine serum albumin 
(BSA), and was centrifuged at 1000 g for 20 min at 4 oC to yield cortical microvessels. The 
microvessels were washed in DMEM, further digested, layered on a continuous 33% Percoll 
gradient and centrifuged again at 1000 g for ten min at 4 oC. The band of CMVECs were seeded 
onto collagen IV and fibronectin-coated glass bottom 35mm culture dishes (MatTek, Ashland, 
MA, USA) and grown until confluent [5-6 d in vitro (DIV)]. 
Fluorescence Confocal Microscopy. Stock solutions of fluoroprobes were prepared in 
dimethyl sulfoxide, (DMSO). Mitochondrial membrane potential was determined by using 
rhodamine 123, (ex: 488 nm, em: >505 nm long pass filter). MitoSOX (ex: 405 nm, em: 
>560 nm long pass filter) was used to measure mitochondrial ROS, specifically superoxide, 
based on the method reported by Robinson et al.7 Fluo- 4 acetoxymethyl ester (Fluo-4 AM, ex: 
488 nm, em: 505 nm long pass filter) was used to study [Ca2+]i, and 4-amino-5-methylamino- 
2’,7’-difluorofluorescein diacetate (DAF-FM, ex: 488 nm, em: >505 nm long pass filter) was 
used to measure NO. The CMVECs were loaded in the dark with a 1:1 mixture of mol/L fluo-
4 AM or mol/L DAF-FM and 20% (w/v) pluronic F-127 diluted in PBS containing glucose 
(1g/L) for 30 min at room temperature. For [Ca2+]i measurements in arterial endothelial cells, 
freshly isolated arteries were cut longitudinally, and pinned to a Sylgard block under minimal 
stretch (tone) with the endothelium facing up using the method described previously.8 
Subsequently, fluo-4 AM was loaded, as described above. MitoSOX (mol/L) or rhodamine 
123 (5 g/ml) solutions were prepared in phenol-free DMEM and CMVECs were loaded with 
fluoroprobes for 15 min at 37oC. Confocal microscopy was performed using a laser scanning 
confocal system (LSM 510 and 7 Live; Zeiss, Jena, Germany) attached to an inverted 
microscope with a Zeiss C-Apochromat 63X /NA 1.2 water immersion objective. MitoSOX 
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fluorescence was determined by Leica SP2 AOB laser confocal microscope. Fluorescence 
images were acquired both before and after application of vehicle (DMSO) or BMS (50 mol/L 
or 100 mol/L) or diazoxide (100 mol/L ) for rhodamine 123, fluo-4 AM and MitoSOX 
whereas DAF-FM images were acquired with or without a 30 min L-NAME pretreatment of 
cells. Imaging conditions such as gain levels and laser power were held constant. Offline analysis 
of images to determine the average pixel intensity of endothelial cells in each field (n=20-30) 
was performed using ImageJ software (National Institute of Health, Bethesda, MD) and the 
results were expressed in relative fluorescence units as % change from the baseline images prior 
to administration of vehicle, BMS, or diazoxide. The ‘n’ value represents average fluorescence 
intensity of all the cells from ‘n’ number of cover slips that were treated with each treatment.   
NO measurements. A stock solution of colloid iron diethyldithiocarbamate, 
Fe2+(DETC)2, was freshly prepared by adding iron sulfate and DETC solutions as described 
previously.9, 10 Aortic ring segments were loaded with Fe2+(DETC)2 solution (0.4 mmol/L) and 
treated with vehicle (DMSO), BMS (50 mol/L), diazoxide (100 mol/L) or spermine NONOate 
[10 mol/L, N-(2-Aminoethyl)-N-(2-hydroxy-2-nitrosohydrazino)-1,2-ethylenediamine] in a 
treatment chamber (Noxygen, Elzach, Germany) at 37 oC for one h. Later, aortic segments were 
transferred to a liquid nitrogen filled, custom built dewar for NO measurements utilizing electron 
spin resonance (ESR) spectrometer (e-scan, Bruker Biospin GmbH, Rheinstetten, Germany) with 
the following settings: microwave power, 40 mW; modulation amplitude, 8G; center field, 2.03 
g; sweep width, 80 G; conversion time, 80 msec; time constant, 20 msec; number of scans, 60; 
sweep time, 10.24 sec. The amount of NO was determined by measuring the total amplitude of 
the ESR signal for each treatment and comparing it with the ESR signal amplitude of the signal 
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following NO-donor spermine NONOate. Finally, diazoxide and BMS induced NO production in 
aortas is expressed as % change from basal levels (vehicle treated).  
Mitochondria and Vascular Signaling. The CMVECs were treated with vehicle 
(DMSO), 25 mol/L BMS, or with diazoxide (100 mol/L) in low glucose DMEM medium at 
37oC for 15-20 min. Similarly, isolated cerebral arteries were treated with vehicle (DMSO), 50 
mol/L BMS, or with diazoxide (100 mol/L). In addition, to evaluate the role of the PI3K 
pathway, arteries and CMVECs were treated with either vehicle or 100 mol/L diazoxide, with 
and without 100 nmol/L wortmannin, in low glucose DMEM medium at 37oC for 15-20 min. 
Cells and arteries were washed and snap frozen in liquid nitrogen. Subsequently, homogenates 
were prepared from the cells to determine the cellular signaling by western blotting. 
Western Blot Analysis. Western blot analyses were performed as previously described.3 
Briefly, equal amounts of extracted protein from homogenates of cerebral arteries or CMVECs 
were separated by 4-20% SDS-PAGE and transferred onto a nitrocellulose membrane (BioRad). 
Membranes were blocked with 1% non-fat milk in Tris-buffered saline and 0.05% Tween-20 for 
1 h at room temperature. Subsequently, the membranes were incubated overnight at 4 0C with the 
primary antibodies for total eNOS and protein kinase B (Akt) (1:4000; BD Transduction 
laboratories) and phosphorylated eNOS (Ser1177) and Akt (Ser473) (1:2000; Cell Signaling 
Technology, Inc.), and -actin (1:2500; Sigma). The membranes were then washed for 2 h in the 
blocking buffer with anti-rabbit IgG (1:10,000 dilution; Jackson ImmunoResearch) conjugated to 
horseradish peroxidase. The final reaction products were visualized using enhanced 
chemiluminescence (SuperSignal West Pico; Pierce, Rockford, IL, USA) and recorded on X-ray 
film. Western blots were analyzed as the immunoband intensity ratio of phosphorylate to the 
corresponding total eNOS or Akt. 
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Drugs, chemicals and solutions. All chemicals were purchased from Sigma (St. Louis, 
MO, USA) except MnTBAP (Calbiochem, San Diego, CA), DETC (Noxygen, Elzach, Germany) 
rhodamine 123, MitoSOX, DAF-FM, fluo-4 AM, Pluronic F-127 (Molecular Probes, Eugene, 
OR), DMEM (Gibco BRL, Grand Island, NY, USA), fetal bovine plasma-derived serum (Animal 
Technologies, Tyler, TX), and Percoll (Amersham Biosciences, Uppsala, Sweden).  
Data analysis and statistics. Results were expressed as mean±SEM; ‘n’ indicates the 
number of independent experiments. Means were compared by one-way ANOVA. Post-hoc 
analysis was done by Tukey’s test. A p<0.05 was considered as statistically significant. 
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